EUVIMEDEUVIMED entdecken
Crossref

The Safety and Efficacy of Intranasal Sympathomimetics in Otorhinolaryngological Practice

Anna Koniewska, Nicol Dardzińska, Maciej Misiołek

Polski Przegląd Otorynolaryngologiczny · 30.06.2026 · 15 (2) · 29-36

DOI: 10.5604/01.3001.0055.7983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polski Przegląd Otorynolaryngologiczny, erschienen am 30.06.2026. Verfasst von Anna Koniewska und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Nasal congestion is one of the most common presentations in ENT practice. To alleviate symptoms, patients and physicians frequently resort to topical imidazoline derivative sympathomimetics. Improper use of these products carries a risk of adverse reactions.

Aim

To present the current state of knowledge regarding the pharmacological properties of intranasal sympathomimetics, their efficacy, safety, effects on mucociliary clearance, applicability in selected patient groups, and risks of rebound congestion (rhinitis medicamentosa).



Review Highlights: Naphazoline, xylometazoline, and oxymetazoline constrict blood vessels by stimulating α-adrenergic receptors, thereby reducing swelling of the nasal mucosa. They are highly effective in treating acute rhinitis. Used over short periods, they support intranasal glucocorticosteroid treatment of chronic and allergic sinusitis. The adverse effects of the drugs of this class include local irritation, ciliary epithelial dysfunction and, less commonly, systemic symptoms. The risk of these effects varies by medication. Long-term use of intranasal sympathomimetics leads to morphological changes within the mucous membrane and the development of rhinitis medicamentosa.

Conclusions

Nasal decongestants are effective and relatively safe medications, provided they are used in short-term treatment in line with the recommendations. Patient education regarding the proper use and the identification of risks of misuse is crucial for achieving therapeutic outcomes and preventing rebound congestion.

Zitieren

APA

Koniewska, A., Dardzińska, N., & Misiołek, M. (2026). The Safety and Efficacy of Intranasal Sympathomimetics in Otorhinolaryngological Practice. Polski Przegląd Otorynolaryngologiczny, 15(2), 29-36. https://doi.org/10.5604/01.3001.0055.7983

Vancouver

Koniewska A, Dardzińska N, Misiołek M. The Safety and Efficacy of Intranasal Sympathomimetics in Otorhinolaryngological Practice. Polski Przegląd Otorynolaryngologiczny. 2026;15(2):29-36. doi:10.5604/01.3001.0055.7983

BibTeX
@article{Koniewska2026,
  author = {Koniewska, Anna and Dardzińska, Nicol and Misiołek, Maciej},
  title = {The Safety and Efficacy of Intranasal Sympathomimetics in Otorhinolaryngological Practice},
  journal = {Polski Przegląd Otorynolaryngologiczny},
  year = {2026},
  volume = {15},
  number = {2},
  pages = {29--36},
  doi = {10.5604/01.3001.0055.7983}
}
Kostenlos starten →